[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial


Maximilien Vermandel took part in Innovation Summit Dublin

Hemerion takes part in the Dublin Innovation Summit

On April 25 and 26, Maximilien Vermandel took part in Innovation Summit Dublin, an international conference organized by Medtech Strategists and attended by a large number of medical device experts and professionals.

Innovation Summit Dublin is one of the largest conferences focusing on financing and partnership development in the medtech sector.

Hemerion was one of some 30 innovative medtech start-ups selected to present their projects to a panel of professionals, experts and financiers.

The event provided an opportunity to meet a number of industry players and to present the next steps in the development of Hemerion’s drug/device technology for the treatment of glioblastoma. The result: fruitful exchanges that open up numerous scientific, clinical and industrial development opportunities, to accelerate the time-to-market for our innovative therapeutic solutions.